Stem Cell Therapy for the Treatment of Nonischemic Cardiomyopathy: A Systematic Review of the Literature and Meta-analysis of Randomized Controlled Trials

Canadian Journal of Cardiology

Volumn 30, Issue 11, 2014, Pages 1378-1384

  Marquis Gravel, Guillaume ^a,b   Stevens, Louis Mathieu ^a,b   Mansour, Samer ^a,b   Avram, Robert ^a   Noiseux, Nicolas ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW DERIVED MONONUCLEAR CELL; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE SIZE; HEART VENTRICLE TACHYCARDIA; HUMAN; META ANALYSIS; NONISCHEMIC CARDIOMYOPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAFETY; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; AUTOTRANSPLANTATION; BIOLOGICAL THERAPY; CARDIOMYOPATHIES; PROCEDURES;

CARDIOMYOPATHIES; CELL- AND TISSUE-BASED THERAPY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84908499173     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.03.026     Document Type: Review

References (44)

1. Fu W., Zhou C.Y., Yu J.K. Anew source of mesenchymal stem cells for articular cartilage repair: MSCs derived from mobilized peripheral blood share similar biological characteristics invitro and chondrogenesis invivo as mscs from bone marrow in a rabbit model. Am J Sports Med 2014, 42:592-601.
2. Al-Shamekh S., Goldberg J.L. Retinal repair with induced pluripotent stem cells. Transl Res 2014, 163:377-386.
3. Huikuri H., Kervinen K., Niemelä M., et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 2008, 29:2723-2732.
4. Menasché P., Hagège A.A., Scorsin M., et al. Myoblast transplantation for heart failure. Lancet 2001, 357:279-280.
5. Chen S., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004, 94:92-95.
6. Manginas A., Goussetis E., Koutelou M., et al. Pilot study to evaluate the safety and feasibility of intracoronary CD1331 and CD1332 CD341 cell therapy in patients with nonviable anterior myocardial infarction. Cath Cardiovasc Interv 2007, 69:773-781.
7. Pokushalov E., Romanov A., Chernyavsky A., et al. Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study. JCardiovasc Transl Res 2010, 3:160-168.
8. Erbs S., Linke A., Adams V., et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 2005, 97:756-762.
9. Yao K., Huang R., Sun A., et al. Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. Eur J Heart Fail 2009, 11:691-698.
10. Jeevanantham V., Butler M., Saad A., et al. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters a systematic review and meta-analysis. Circulation 2012, 126:551-568.
11. Rende X., Song D., Yichao Z., Jun P., Ben H. Autologous transplantation of bone-marrow/blood-derived cells for chronic ischemic heart disease: a systematic review and meta-analysis. Can J Cardiol 2014, in press.
12. Baldasseroni S., Opasich C., Gorini M., et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002, 143:398-405.
13. Stehlik J., Edwards L.B., Kucheryavaya A.Y., et al. The Registry of the International Society of Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplantation Report-2011. JHeart Lung Transplant 2011, 30:1078-1094.
14. Fischer-Rasokat U., Assmus B., Seeger F.H., et al. Apilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2009, 2:417-423.
15. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:332-336.
16. Cochrane Handbook for Systematic Reviews of Interventions. Available at: . Accessed Novmber 27,2013. http://handbook.cochrane.org.
17. Seth S., Bhargava B., Narang R., et al. The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) Trial. JAm Coll Cardiol 2010, 55:1643-1644.
18. Vrtovec B., Poglagen G., Lezaic L., et al. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res 2013, 112:165-173.
19. Bocchi E., Bacal F., Guimaraes G., et al. Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure. Int J Cardiol 2010, 138:94-97.
20. Chin S., Poey A.C., Wong C.Y., et al. Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy. Cytotherapy 2011, 13:814-821.
21. Arom K., Ruengsakulrach P., Belkin M., Tiensuwan M. Intramyocardial angiogenic cell precursors in nonischemic dilated cardiomyopathy. Asian Cardiovasc Thorac Ann 2009, 17:382-388.
22. Kirillov A., Fatkhudinov T.K., Dyachkov A.V., et al. Transplantation of allogenic cells in the therapy of patients with dilated cardiomyopathy. Bull Exp Biol Med 2007, 144:635-639.
23. Kalil R., Ott D., Sant'Anna R., et al. Autologous transplantation of bone marrow mononuclear stem cells by mini-thoracotomy in dilated cardiomyopathy: technique and early results. Sao Paulo Med J 2008, 126:75-81.
24. Schannwell C., Kostering M., Zeus T., et al. Dusseldorfer autologous bone marrow cells in dilated cardiomyopathy trial (Dusseldorfer ABCD Study). JKardiol 2008, 15:23-30.
25. Francis D., Mielewczik M., Zargaran D., Cole G.D. Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions. Int J Cardiol 2013, 168:3381-3403.
26. Wu Z., Yuan M.Y., Li H.M., et al. Autologous peripheral blood stem cells transplantation for the treatment of dilated cardiomyopathy: A 24-month follow-up in 38 cases. JClin Rehabil Tiss Eng Res 2010, 14:121-125.
27. Xiao W., Gao L.J., Gao C.Y., et al. Comparative study on the efficacy of intracoronary infusion with various types of autologous bone marrow stem cells for patients with dilated cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi 2012, 40:575-578. [in Chinese].
28. Wang J., Xie X.J., He H., et al. Aprospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi 2006, 34:107-110. [in Chinese].
29. Huang R.Y., Li Y.L., Zhang Y.Q., et al. Transplantation of autologous bone marrow mononuclear cells on patients with idiopathic dilated cardiomyopathy: early results on effect and security. Zhonghua Xin Xue Guan Bing Za Zhi 2006, 34:111-113. [in Chinese].
30. Xiao W., Gao C.Y., Dai G.Y., et al. Autologous bone marrow mesenchymal stem cells for myocardial renewal and repair. Chinese J Tiss Eng Res 2012, 16:5081-5086.
31. Zhang T., Liu C., Yang J., Zhang X., Li W. Peripheral blood stem cell transplantation in the treatment of dilated cardiomyopathy: a 3-month follow-up in 42 cases. JClin Rehabil Tiss Eng Res 2008, 12:3045-3048.
32. Fatkhutdinov T., D'yachkov A.V., Koroteyev A.V., Goldstein D.V., Bochkov N.P. Safety and efficiency of transplantation of allogenic multipotent stromal cells in surgical treatment of dilatated cardiomyopathy. Bull Exp Biol Med 2010, 149:119-124.
33. Bartolucci J., Carrion F., Lamich R., et al. Transplantation of autologous bone marrow cells, improve the ejection fraction in patients with dilated cardiomyopathy of diverse etiology. Cytotherapy 2013, 15:S30-S31.
34. Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells by Mini-Thoracotomy (STEMDILCARD). Available at: . Accessed November 12,2013. http://clinicaltrials.gov/show/NCT00615394.
35. Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy (REGEN-DCM). Available at: . Accessed November 12,2013. http://clinicaltrials.gov/show/NCT01302171.
36. Progenitor Cell Therapy in Dilative Cardiomyopathy. Available at: . Accessed November 12,2013. http://clinicaltrials.gov/show/NCT00284713.
37. Cell Therapy in dilated cardiomyopathy. Available at: . Accessed November 12,2013. http://clinicaltrials.gov/show/NCT00333827.
38. Sant'Anna R., Fracasso J., Valle F.H., et al. Intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy is not associated with improvement of heart function evaluated by cardiac resonance imaging. Circulation 2011, 124:A11769. (abstract).
39. Assmus B., Tonn T., Seeger F.H., et al. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy. JAm Coll Cardiol 2010, 55:1385-1394.
40. Seeger F., Rasper T., Fischer A., et al. Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair. Circ Res 2012, 111:854-862.
41. Seeger F., Tonn T., Krzossok N., Zeiher A.M., Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 2007, 28:766-772.
42. Meluzin J., Mayer J., Groch L., et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 2006, 152:975-1015.
43. Vrtovec B., Poglagen G., Lezaic L., et al. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy. Circulation 2013, 128:S42-S49.
44. Brunskill S., Hyde C.J., Doree C.J., Watt S.M., Martin-Rendon E. Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. Eur J Heart Fail 2009, 11:887-896.